Goldstein Allan L
- SEC CIK
- 0000905390
No open-market purchases or sales filed in the past year.
Current role at each company
- RGRX Regenerx Biopharmaceuticals IncDirectoras of May 19, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Goldstein Allan L as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 6, 2021 (view filing)4:34 PM ET | Jun 30 | 6 daysLate | Goldstein Allan LDirector | PPurchase | +125.0K | $0.20 | +$25.0K | +8.3%1.64M after | |
| Jul 6, 2021 (view filing)4:34 PM ET | Jun 30 | 6 daysLate | Goldstein Allan LDirector | PPurchase | +187.5K | $0.00 | $0 | –93.8K after | Derivative2 lots |